Wedbush Securities’s Insys Therapeutics, Inc. INSY Stock Holding History

Wedbush Securities’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,500	Closed	-$3K	–	1055
2019 Q2	$3K	Buy	+10,500	New	+$28.3K	﹤0.01%	982

Wedbush Securities's INSY Position: Q3 2019 in Review

Wedbush Securities sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 10,500 shares — an estimated $3K sold.

Wedbush Securities first reported a position in INSY in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

Wedbush Securities reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Wedbush Securities sold 10,500 Insys Therapeutics, Inc. shares in Q3 2019, an estimated $3K.
Wedbush Securities first reported a position in Insys Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Wedbush Securities's Insys Therapeutics, Inc. position peaked at $3K in Q2 2019.
4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.